3.8 Article

Biobanking-Budgets and the Role of Pathology Biobanks in Precision Medicine

Journal

ACADEMIC PATHOLOGY
Volume 4, Issue -, Pages -

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/2374289517702924

Keywords

biorepository; informed consent; precision medicine; The Cancer Genome Atlas; the Cancer Human Biobank

Categories

Funding

  1. NIH [AA022122, AI112887]
  2. NCI [BPV HHSN261200800001E, CPTAC HHSN261201600011I]

Ask authors/readers for more resources

Biobanks have become an important component of the routine practice of pathology. At the 2016 meeting of the Association of Pathology Chairs, a series of presentations covered several important aspects of biobanking. An often overlooked aspect of biobanking is the fiscal considerations. A biobank budget must address the costs of consenting, procuring, processing, and preserving high-quality biospecimens. Multiple revenue streams will frequently be necessary to create a sustainable biobank; partnering with other key stakeholders has been shown to be successful at academic institutions which may serve as a model. Biobanking needs to be a deeply science-driven and innovating process so that specimens help transform patient-centered clinical and basic research (ie, fulfill the promise of precision medicine). Pathology's role must be at the center of the biobanking process. This ensures that optimal research samples are collected while guaranteeing that clinical diagnostics are never impaired. Biobanks will continue to grow as important components in the mission of pathology, especially in the era of precision medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available